ArticleInternational journal of medical sciences2026
Predictors of One-Year Mortality in Hospitalized Patients with Splenic Infarction: Survival Analysis of a Retrospective Cohort in Taiwan.
Article in International journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Splenic infarction, an uncommon disease, has been demonstrated to be associated with substantial short-term mortality. Given the limited evidence on long-term mortality, this investigation examined the clinical and radiological characteristics of splenic infarction, its long-term prognosis, and predictors of mortality. Methods: This retrospective cohort study at a tertiary care hospital in Taiwan enrolled adult inpatients with first-episode splenic infarction diagnosed on computed tomography from January 2011 to May 2022. The primary outcome was 1-year all-cause mortality. Kaplan-Meier analysis and multivariate weighted Cox regression were applied for survival analysis. Results: The cohort included 304 individuals with an average age of 65.4 years. The mean CCI was 6, and active malignancy was observed in 49%. The estimated 1-year all-cause mortality rate was 61%, and the median survival time was 89 days. Compared with survivors, non-survivors exhibited significantly higher rates of left-sided pleural effusion, peri-splenic ascites, multiple or total infarction, and both portal and splenic vein thrombosis on CT imaging. Older age, active malignancy, decreased hemoglobin levels, low platelet counts, prolonged INR, elevated D-dimer, and peri-splenic ascites were independent predictors of mortality. Conclusion: In splenic infarction, 1-year mortality is notably high. The identified independent prognostic factors included age, malignancy, laboratory findings, and radiologic features. These findings may assist clinicians in early risk stratification for hospitalized patients with splenic infarction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.